• +1-646-491-9876
    • +91-20-67278686

    Search

    GBI Research

    Report name Publication Date Price
    (Single Copy Price)
    Buy Now
    Antibacterial Therapeutics-High levels of Pipeline Innovation Focused on the Increasing Unmet Need Associated with Antibiotic Resistance
    01-Jan-2018

    $6,995.00


    Buy Now
    Lower Female Reproductive System Cancers Drug Development Pipeline Review 2017
    26-Dec-2017

    $3,995.00


    Buy Now
    Bladder and Ureter Cancer Drug Development Pipeline Review 2017
    22-Dec-2017

    $3,995.00


    Buy Now
    Global Genetic Disorders Drugs Market to 2023-A Rapidly Growing Treatment Landscape Driven by Targeted Complement System Inhibitors and Enzyme Replacement Therapies to Treat PNH and Lysosomal Storage Disease
    15-Dec-2017

    $4,995.00


    Buy Now
    Frontier Pharma-Transplantation Therapeutics-A Highly Innovative Pipeline with a Range of Adaptive and Innate Immune-Targeting Programs Focusing on Graft-Versus-Host Disease and Kidney Transplantation
    01-Dec-2017

    $6,995.00


    Buy Now
    COPD Therapeutics in Asia-Pacific Markets to 2023-Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Novel Therapies
    01-Dec-2017

    $4,995.00


    Buy Now
    Global Cardiovascular Disease Drugs Market to 2023-Expiries Acquisitions and New Products for Deep Vein Thrombosis Pulmonary Arterial Hypertension and Dyslipidemia to Shake-Up the Competitive Landscape
    01-Dec-2017

    $4,995.00


    Buy Now
    Swine and Avian Influenza Drug Development Pipeline Review 2017
    20-Nov-2017

    $3,995.00


    Buy Now
    Sickle Cell Disease Drug Development Pipeline Review 2017
    17-Nov-2017

    $3,995.00


    Buy Now
    Gastric and Esophageal Cancer Drug Development Pipeline Review 2017
    16-Nov-2017

    $3,995.00


    Buy Now
    Cancer Supportive Care Drug Development Pipeline Review 2017
    14-Nov-2017

    $3,995.00


    Buy Now
    Hemophilia A and B Therapeutics in Asia-Pacific Markets to 2023-Growth Driven by Increasing Treatment-Receiving Pool Launch of Long-Acting Replacement Therapies and Non-factor Therapy
    01-Nov-2017

    $4,995.00


    Buy Now
    Frontier Pharma: Neurodegenerative Diseases-Protein Misfolding Targets and Neuromodulators Dominate the First-in-Class Pipeline and Lead the Way as Potential Disease-Modifying Therapies in AD and PD
    01-Nov-2017

    $6,995.00


    Buy Now
    Frontier Pharma: Renal Diseases-High Degree of Innovation and Diversity with Products Targeting Immune and Hormone Signaling Dominating the Pipeline for Chronic Kidney Disease
    03-Oct-2017

    $6,995.00


    Buy Now
    Type 2 Diabetes Mellitus Therapeutics in South-East Asia Markets to 2023-Increasing Usage of Newer Therapies and Expanding Treatment Population to Encourage Robust Growth
    01-Oct-2017

    $4,995.00


    Buy Now
    Frontier Pharma: Ophthalmology Therapeutics-Gene Therapies and First-in-Class Targets Offer Novel Treatments for Substantial Unmet Needs in a Pipeline Dominated by Angiogenic and Immune Signaling Drugs
    01-Oct-2017

    $6,995.00


    Buy Now
    Pneumonia Drug Development Pipeline Review, 2017
    26-Sep-2017

    $3,995.00


    Buy Now
    Sleep Disorders Drug Development Pipeline Review, 2017
    26-Sep-2017

    $3,995.00


    Buy Now
    Male Health Drug Development Pipeline Review, 2017
    25-Sep-2017

    $3,995.00


    Buy Now
    Colorectal Cancer Drug Development Pipeline Review, 2017
    22-Sep-2017

    $3,995.00


    Buy Now
    Behavioral Disorders Drug Development Pipeline Review, 2017
    14-Sep-2017

    $3,995.00


    Buy Now
    Global Diabetes Drugs Market to 2023-A Diversifying Treatment Landscape as GLP-1 Receptor Agonists and SGLT-2 Inhibitors Gain Ground Following Landmark Cardiac Outcomes
    13-Sep-2017

    $4,995.00


    Buy Now
    Frontier Pharma: Cancer Immunotherapies-First-in-Class Pipeline Dominated by Immunomodulators and PD-1 Like Targets
    01-Sep-2017

    $6,995.00


    Buy Now
    Global Respiratory Drugs Market to 2023-A Changing Therapeutic Landscape as Key Patents Expire and Biologics Targeted Therapies and CFTR Modulators for Asthma and Cystic Fibrosis Treatment Emerge as Market Growth Drivers
    01-Sep-2017

    $4,995.00


    Buy Now
    Hepatitis Drug Development Pipeline Review, 2017
    01-Aug-2017

    $3,995.00


    Buy Now
    Showing 1 to 25 of 150 (6 Pages)